Lectin-conjugated microspheres for eradication of Helicobacter pylori infection and interaction with mucus

International Journal of Pharmaceutics

Volumn 470, Issue 1-2, 2014, Pages 28-40

  Adebisi, Adeola O ^a   Conway, Barbara R ^a  

^a UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

Author keywords

Chitosan; Concanavalin A; Ethylcelluose; Helicobacter pylori; Microspheres; Mucoadhesive

Indexed keywords

CHITOSAN; CLARITHROMYCIN; CONCANAVALIN A; ETHYL CELLULOSE; LECTIN; MICROSPHERE; SOLVENT; STOMACH MUCIN; ANTIINFECTIVE AGENT; ARTIFICIAL MEMBRANE; CELLULOSE; MUCIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; CONJUGATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; EVAPORATION; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HELICOBACTER INFECTION; IN VITRO STUDY; MUCOADHESION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SURFACE PROPERTY; SWINE; ZETA POTENTIAL; ADHESION; ANALOGS AND DERIVATIVES; ANIMAL; ARTIFICIAL MEMBRANE; CHEMISTRY; DIFFUSION; DRUG STABILITY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; INFRARED SPECTROSCOPY; METABOLISM; MUCUS; POWDER DIFFRACTION; STOMACH JUICE; STOMACH MUCOSA; X RAY DIFFRACTION;

ADHESIVENESS; ANIMALS; ANTI-BACTERIAL AGENTS; CELLULOSE; CHITOSAN; CLARITHROMYCIN; CONCANAVALIN A; DIFFUSION; DRUG STABILITY; GASTRIC JUICE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; MEMBRANES, ARTIFICIAL; MICROSPHERES; MUCINS; MUCUS; POWDER DIFFRACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SWINE; X-RAY DIFFRACTION;

EID: 84901022710     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.04.070     Document Type: Article

References (62)

1. A. Adebisi, and B.R. Conway Gastroretentive microparticles for drug delivery applications J. Microencapsul. 28 2011 689 708
2. A. Ahuja, R.K. Khar, and J. Ali Mucoadhesive drug delivery systems Drug Dev. Ind. Pharm. 23 1997 489 515
3. Y. Akiyama, N. Nagahara, E. Nara, M. Kitano, S. Iwasa, I. Yamamoto, J. Azuma, and Y. Ogawa Evaluation of oral mucoadhesive microspheres in man on the basis of the pharmacokinetics of furosemide and riboflavin, compounds with limited gastrointestinal absorption sites J. Pharm. Pharmacol. 50 1998 159 166
4. N.M. Anande, S.K. Jain, and N.K. Jain Con-A conjugated mucoadhesive microspheres for the colonic delivery of diloxanide furoate Int. J. Pharm. 359 2008 182 189
5. S.H. Barondes, D.N. Cooper, M.A. Gitt, and H. Leffler Galectins: structure and function of a large family of animal lectins J. Biol. Chem. 269 1994 20807 20810
6. H. Batchelor, B. Conway, and R.O. Williams Targeting the infections within the gastro- intestinal tract R.O. Williams, D.R. Taft, J.T. McConville, Advanced Drug Formulation Design to Optimize Therapeutic Outcomes (Drugs and the Pharmaceutical Sciences) 2007 Informa Healthcare New York 217 244
7. F. Bazzoli, G. Bianchi Porro, G. Maconi, M. Molteni, P. Pozzato, and R.M. Zagari Treatment of Helicobacter pylori infection indications and regimens: an update Dig. Liver Dis. 34 2002 70 83
8. B.M. Boddupalli, Z.N. Mohammed, R.A. Nath, and D. Banji Mucoadhesive drug delivery system: an overview J. Adv. Pharm. Technol. Res. 1 2010 381 387
9. G. Cammarota, M. Sanguinetti, A. Gallo, and B. Posteraro Review article: biofilm formation by Helicobacter pylori as a target for eradication of resistant infection Aliment. Pharmacol. Ther. 36 2012 222 230
10. K.P. Chowdary, and Y.S. Rao Mucoadhesive microspheres for controlled drug delivery Biol. Pharm. Bull. 27 2004 1717 1724
11. M.K. Chun, H. Sah, and H.K. Choi Preparation of mucoadhesive microspheres containing antimicrobial agents for eradication of H. pylori Int. J. Pharm. 297 2005 172 179
12. P. Costa, and J.M.S. Lobo Influence of dissolution medium agitation on release profiles of sustained-release tablets Drug Dev. Ind. Pharm. 27 2001 811 817
13. L.H.H.O. Damink, P.J. Dijkstra, M.J.A. vanLuyn, P.B. vanWachem, P. Nieuwenhuis, and J. Feijen Cross-linking of dermal sheep collagen using a water-soluble carbodiimide Biomaterials 17 1996 765 773
14. J. Desai, K. Alexander, and A. Riga Characterization of polymeric dispersions of dimenhydrinate in ethyl cellulose for controlled release Int. J. Pharm. 308 2006 115 123
15. B.E. Dunn, H. Cohen, and M.J. Blaser Helicobacter pylori Clin. Microbiol. Rev. 10 1997 720 741
16. A.H. El-Kamel, M.S. Sokar, S.S. Al Gamal, and V.F. Naggar Preparation and evaluation of ketoprofen floating oral delivery system Int. J. Pharm. 220 2001 13 21
17. P.O. Erah, A.F. Goddard, D.A. Barrett, P.N. Shaw, and R.C. Spiller The stability of amoxycillin, clarithromycin and metronidazole in gastric juice: relevance to the treatment of Helicobacter pylori infection J. Antimicrob. Chemother. 39 1997 5 12
18. I. Ezpeleta, M.A. Arangoa, J.M. Irache, S. Stainmesse, C. Chabenat, Y. Popineau, and A.-M. Orecchioni Preparation of Ulex europaeus lectin-gliadin nanoparticle conjugates and their interaction with gastrointestinal mucus Int. J. Pharm. 191 1999 25 32
19. G. Fundueanu, M. Constantin, A. Dalpiaz, F. Bortolotti, R. Cortesi, P. Ascenzic, and E. Menegatti Preparation and characterization of starch/cyclodextrin bioadhesive microspheres as platform for nasal administration of gabexate mesylate (Foys) in allergic rhinitis treatment Biomaterials 25 2004 159 170
20. F. Gabor, M. Wirth, B. Jurkovich, I. Haberl, G. Theyer, G. Walcher, and G. Hamilton Lectin-mediated bioadhesion: pro-teolytic stability and binding-characteristics of wheat germagglu-tinin and Solanum tuberosum lectin on Caco-2, HT-29 and human colonocytes J. Control. Rel. 49 1997 27 37
21. S.D. Georgopoulos, V. Papastergiou, and S. Karatapanis Helicobacter pylori eradication therapiesin the era of increasing antibiotic resistance: a paradigm shift to improved efficacy Gastroenterol. Res. Pract. 2012 2012 9
22. I.J. Goldstein, and R.D. Poretz Isolation, physico-chemical characterization, and carbohydrate-binding specificity of lectins I.E. Liener, The Lectins: Properties, Functions and Applications in Biology and Medicine 1986 Academic Press Orlando, Florida 233 247
23. L.E. Gustavson, J.F. Kaiser, A.L. Edmonds, C.S. Locke, M.L. DeBartolo, and D.W. Schneck Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state Antimicrob. Agents Chemother. 39 1995 2078 2083
24. T. Higuchi Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J. Pharm. Sci. 52 1963 1145 1149
25. Y.C. Huang, C.H. Chiang, and M.K. Yeh Optimizing formulation factors in preparing chitosan microparticles by spray-drying method J. Microencapsul. 20 2003 247 260
26. K. Iijima, H. Sekine, T. Koike, A. Imatani, S. Ohara, and T. Shimosegawa Long-term effect of Helicobacter pylori eradication on the reversibility of acid secretion in profound hypochlorhydria Aliment. Pharmacol. Ther. 19 2004 1181 1188
27. J.M. Irache, C. Durrer, D. Duchene, and G. Ponchel Preparation and characterization of lectin-latex conjugates for specific bioadhesion Biomaterials 15 1994 899 904
28. S.K. Jain, and M.S. Jangdey Lectin conjugated gastroretentive multiparticulate delivery system of clarithromycin for the effective treatment of Helicobacter pylori Mol. Pharm. 6 2009 295 304
29. Y. Kawahara, M. Mizuno, T. Yoshino, K. Yokota, K. Oguma, H. Okada, S. Fujiki, and Y. Shiratori HLA-DQA1*0103-DQB1*0601 haplotype and Helicobacter pylori-positive gastric mucosa-associated lymphoid tissue lymphoma Clin. Gastroenterol. Hepatol. 3 2005 865 868
30. K. Khanvilkar, M.D. Donovan, and D.R. Flanagan Drug transfer through mucus Adv. Drug Deliv. Rev. 48 2001 173 193
31. D.C. Kilpatrick, A. Pusztai, G. Grant, C. Graham, and S.W.B. Ewen Tomato lectin resists digestion in the mammalian alimentary canal and binds to intestinal villi without deleterious effects FEBS Lett. 185 1985 299 305
32. U.B. Kompella, and V.H.L. Lee Delivery systems for penetration enhancement of peptide and protein drugs: design considerations Adv. Drug Deliv. Rev. 8 1992 115 162
33. R.W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N.A. Peppas Mechanisms of solute release from porous hydrophilic polymers Int. J. Pharm. 15 1983 25 35
34. S.P. Lee, and J.F. Nicholls Diffusion of charged ions in mucus gel - effect of net charge Biorheology 24 1987 565 569
35. F.S. Lehmann, L. Terracciano, I. Carena, C. Baeriswyl, J. Drewe, L. Tornillo, G. De Libero, and C. Beglinger In situ correlation of cytokine secretion and apoptosis in Helicobacter pylori-associated gastritis Am. J. Physiol. Gastrointest. Liver Physiol. 283 2002 G481 488
36. 4 for hyperthermic treatment. Advances in Natural Sciences Nanosci. Nanotechnol. 3 2012 015006
37. A. Martinac, J. Filipović-Grčić, D. Voinovich, B. Perissutti, and E. Franceschinis Development and bioadhesive properties of chitosan-ethylcellulose microspheres for nasal delivery Int. J. Pharm. 291 2005 69 77
38. M.N. Mordi, M.D. Pelta, V. Boote, G.A. Morris, and J. Barber Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy J. Med. Chem. 43 2000 467 474
39. N. Muramatsu, and T. Kondo An approach to prepare microparticles of uniform size J. Microencapsul. 12 1995 129 136
40. C.J. Murray, and A.D. Lopez Mortality by cause for eight regions of the world: global burden of disease study Lancet 349 1997 1269 1276
41. B. Naisbett, and J. Woodley The potential use of tomato lectin for oral drug delivery: 3 bioadhesion in vivo Int. J. Pharm. 114 1995 227 236
42. N. Najib, and M.S. Suleiman The kinetics of drug release from ethylcellulose solid dispersions Drug Dev. Ind. Pharm. 11 1985 2169 2181
43. Y. Nakagawa, S. Itai, T. Yoshida, and T. Nagai Physicochemical properties and stability in the acidic solution of a new macrolide antibiotic, clarithromycin, in comparison with erythromycin Chem. Pharm. Bull. (Tokyo) 40 1992 725 728
44. E.J. Nassar, K.J. Ciuffi, S.J.L. Ribeiro, and Y. Messaddeq Europium incorporated in silica matrix obtained by sol-gel: luminescent materials Mater. Res. 6 2003 557 562
45. D.A. Norris, N. Puri, and P.J. Sinko The effect of physical barriers and properties on the oral absorption of particulates Adv. Drug Deliv. Rev. 34 1998 135 154
46. F. Noqueira, I.C. Gonçalves, and M.C.L. Martins Effect of gastric environment on Helicobacter pylori adhesion to a mucoadhesive polymer Acta Biomater. 9 2013 5208 5215
47. K. Park, and J.R. Robinson Bioadhesive polymers as platforms for oral-controlled drug delivery: method to study bioadhesion Int. J. Pharm. 19 1984 107 127
48. V.K. Pawar, S. Kansal, G. Garg, R. Awasthi, D. Singodia, and G.T. Kulkarni Gastroretentive dosage forms: a review with special emphasis on floating drug delivery systems Drug Deliv. 18 2011 97 110
49. W.L. Peterson Helicobacter pylori and peptic ulcer disease N. Engl. J. Med. 324 1991 1043 1048
50. P.S. Rajinikanth, and B. Mishra Floating in situ gelling system for stomach site-specific delivery of clarithromycin to eradicate H. pylori J. Control. Rel. 125 2008 33 41
51. R. Ravindra, A.K. Rao, and A.A. Khan A qualitative evaluation of water and monomethyl hydrazine in ethylcellulose membrane J. Appl. Polym. Sci. 72 1999 689 700
52. J.M. Rini Lectin structure Ann. Rev. Biophys. Biomol. Struct. 24 1995 551 577
53. D. Rothenbacher, and H. Brenner Burden of Helicobacter pylori and H. pylori-related diseases in developed countries: recent developments and future implications Microb. Infect. 5 2003 693 703
54. P.D. Scholes, A.G.A. Coombes, L. Illum, S.S. Davis, J.F. Watts, C. Ustariz, M. Vert, and M.C. Davies Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS J. Control. Rel. 59 1999 261 278
55. A. Streubel, J. Siepmann, and R. Bodmeier Drug delivery to the upper small intestine window using gastroretentive technologies Curr. Opin. Pharmacol. 6 2006 501 508
56. S. Suerbaum, and P. Michetti Helicobacter pylori infection N. Engl. J. Med. 347 2002 1175 1186
57. J.B. Sumner, N. Gralën, and I.-B. Eriksson-Quensel The molecular weights of urease, canavalin, concanavalin A and concanavalin B Science 87 1938 395 396
58. H. Suzuki, and H. Ishii Role of apoptosis in Helicobacter pylori-associated gastric mucosal injury J. Gastroenterol. Hepatol. 15 2000 D46 D54
59. R. Talukder, and R. Fassihi Gastroretentive delivery systems: a mini review Drug Dev. Ind. Pharm. 30 2004 1019 1028
60. R.B. Umamaheshwari, and N.K. Jain Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori J. Drug Target. 11 2003 415 424
61. A. Weissenbock, M. Wirth, and F. Gabor WGA-grafted PLGA-nano spheres: preparation and association with Caco-2 single cells J. Control. Rel. 99 2004 383 392
62. J. Zheng, C. Liu, D. Bao, Y. Zhao, and X. Ma Preparation and evaluation of floating-bioadhesive microparticles containing clarithromycin for the eradication of Helicobacter pylori J. Appl. Polym. Sci. 102 2006 2226 2232